SC 13-D

Company

Inmune Bio, Inc.

Filed

February 11, 2019

Accession Number

0001640334-19-000220

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →